[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Crinetics Pharmaceuticals Inc (CRNX)

Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

ATAI : 7.29 (+0.69%)
HLX : 10.38 (-1.52%)
CRNX : 84.72 (-0.04%)
DSGR : 34.69 (-0.53%)
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Crinetics Pharmaceuticals...

CRNX : 84.72 (-0.04%)
VRTX : 528.19 (+2.45%)
Are UTZ, VEEE, CRNX Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

CRNX : 84.72 (-0.04%)
VEEE : 10.75 (+0.09%)
UTZ : 14.16 (+0.07%)
SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--CRNX, PSBQ, UTZ, and VEEE

NEW YORK , Aug. 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...

CRNX : 84.72 (-0.04%)
VEEE : 10.75 (+0.09%)
PSBQ : 52.7400 (+0.34%)
UTZ : 14.16 (+0.07%)
Are ACA, CRNX, LEG Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

CRNX : 84.72 (-0.04%)
ACA : 145.35 (+0.23%)
LEG : 9.36 (-2.09%)
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

      Announced Vertex Agreement to Acquire Crinetics for Total Equity Value of Approximately $10.0 Billion, or Approximately $8.8B Net of Estimated Cash Acquired        PALSONIFY®...

CRNX : 84.72 (-0.04%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--ACA, CRNX, LEG, and LPSN

NEW YORK , Aug. 3, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

CRNX : 84.72 (-0.04%)
LPSN : 2.84 (unch)
ACA : 145.35 (+0.23%)
LEG : 9.36 (-2.09%)
Are UTZ, CRNX, SOLS Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

SOLS : 60.09 (-3.93%)
CRNX : 84.72 (-0.04%)
UTZ : 14.16 (+0.07%)
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG

NEW YORK , July 23, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

PASG : 4.61 (+1.43%)
CRNX : 84.72 (-0.04%)
SLP : 18.36 (unch)
NCSM : 50.39 (-1.47%)
Are CRNX, VEEE, NXTC, TCBK Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

CRNX : 84.72 (-0.04%)
VEEE : 10.75 (+0.09%)
NXTC : 6.75 (-12.48%)
TCBK : 56.70 (-1.32%)

Barchart Exclusives

LHX Stock in Focus as L3Harris Technologies Ousts CEO
L3Harris ousts CEO Christopher Kubasik and names Sam Mehta as new chief executive. Here’s what the leadership change really means for LHX shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.